XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating activities:    
Net loss $ (85,348) $ (46,266)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 4,934 1,401
Depreciation 4,039 4,106
Debt related fees and amortization expense 5,199 3,045
Intangibles and other amortization expense 35 35
Accretion and other expenses of Series A preferred units 5,920 7,928
Loss on asset disposals 47 0
Loss (gain) on debt extinguishment 49,386 (1,134)
Gain on litigation (1,400) 0
Loss on lease termination 736 0
Provision for bad debts 0 144
Changes in operating assets and liabilities:    
Accounts receivable (7,987) 50
Inventories (5,639) (902)
Prepaid expenses 2,786 (2,847)
Other assets (505) 2,475
Accounts payable 8,754 (4,624)
Accrued interest expense and fees 12,801 9,256
Other liabilities (10,065) 7,340
Net cash used in operating activities (16,307) (19,993)
Investing activities:    
Capital expenditures (28,931) (18,771)
Grant proceeds and other reimbursements received for capital expenditures 7,401 1,224
Net cash used in investing activities (21,530) (17,547)
Financing activities:    
Proceeds from borrowings 39,860 0
Repayments of borrowings (16,191) (53,523)
Lender debt renewal and waiver fee payments (1,169) (1,008)
Grant proceeds received for capital expenditures 0 115
Payments on finance leases (314) (373)
Proceeds from issuance of common stock in equity offering 7,996 94,203
Proceeds from the exercise of stock options 206 1,104
Proceeds from Series A preferred units financing 0 3,130
Series A preferred financing redemption 0 (300)
Net cash provided by financing activities 30,388 43,348
Effect of exchange rate changes on cash and cash equivalents (51) (11)
Net change in cash and cash equivalents for period (7,500) 5,797
Cash and cash equivalents at beginning of period 7,751 592
Cash and cash equivalents at end of period 251 6,389
Supplemental disclosures of cash flow information, cash paid:    
Cash paid for interest 15,476 5,646
Income taxes paid 10 7
Supplemental disclosures of cash flow information, non-cash transactions:    
Subordinated debt extension fees added to debt 680 680
Debt fees added to revolving lines 800 0
Fair value of warrants issued to subordinated debt holders 1,939 1,546
Fair value of warrants issued for guarantee fees 2,012 0
Fair value of warrants issued to lender for debt issuance costs 3,158 0
Fair value of stock issued to lender 1,335 0
Lender debt extension, waiver, and other fees added to debt 583 608
Capital expenditures in accounts payable 15,957 4,695
Payment of debt added to revolving lines 16,266 0
Financing lease liabilities arising from obtaining right of use assets 2,932 113
Capital expenditures purchased on financing 290 55
Issuance of equity to pay off accounts payable $ 0 $ 893